Abstract: A method of managing a design lifecycle of a structural part includes accessing memory storing computer-readable program code for identifying a supplier for the structural part. The method includes executing the code to cause an apparatus to identify the supplier. The method also includes generating a first design of the structural part, the first design describing a geometry of the structural part and requirements for attributes of the structural part. The method also includes performing a search of a database of existing designs for a second design based on search criteria including multiple ones of the geometry and the requirements, and selecting a design from the first design and the second design based on the search. The method also includes performing a multiple-criteria decision analysis to evaluate the design, identifying the supplier from multiple suppliers, and outputting an indication of the supplier for use in ordering of the structural part.

Abstract: Terahertz metamaterials comprise a periodic array of resonator elements disposed on a dielectric substrate or thin membrane, wherein the resonator elements have a structure that provides a tunable magnetic permeability or a tunable electric permittivity for incident electromagnetic radiation at a frequency greater than about 100 GHz and the periodic array has a lattice constant that is smaller than the wavelength of the incident electromagnetic radiation. Microfabricated metamaterials exhibit lower losses and can be assembled into three-dimensional structures that enable full coupling of incident electromagnetic terahertz radiation in two or three orthogonal directions. Furthermore, polarization sensitive and insensitive metamaterials at terahertz frequencies can enable new devices and applications.

Abstract: The present invention provides for a method of evolving and selecting cells resistant to a selective agent by inducing directed evolution in continuous culture while applying both a mutagenic and selective agent to the cells to determine the cells having resistance. This also provides a method of generating mutant drug targets useful for screening for effective compounds.

Abstract: This invention provides for a chewable veterinary formulation, which does not contain animal products, which comprises:

Abstract: This invention provides for a chewable veterinary formulation, which does not contain animal products, which comprises: